Skip to content
Open access

Disease-associated MYH11 tail variants disrupt vascular smooth muscle myosin II filament dynamics and cell mechanics

Oct 2026 · bioRxiv · 0 citations · 48 references
Medicine Biology

Abstract

Smooth muscle myosin II (SMII), encoded by MYH11, is the principal motor driving vascular smooth muscle cell (VSMC) contraction. How disease-associated MYH11 variants alter SMII behavior in living cells remains poorly understood. We directly visualized two human MYH11 tail variants in VSMCs: pathogenic K1256del and a variant of uncertain significance A1839V, identified in a patient with severe aortoiliac aneurysmal disease. Both variants reduced SMII filament assembly and VSMC contractile output, but with distinct severity. A1839V predominantly retained filamentous organization and displayed partial agonist-induced stabilization, consistent with an intermediate cellular phenotype. In contrast, K1256del severely disrupted filament architecture and behavior, including reduced focal adhesion organization, increased SMII network flow and accelerated filament exchange. Furthermore, K1256del abolished the filament stabilization response to induced contraction. These findings identify failure of SMII filament stabilization as a cellular mechanism linking MYH11 variation to impaired VSMC mechanics. More broadly, they show that direct live-cell phenotyping can distinguish variant-specific defects in the contractile machinery, providing a scalable functional strategy to complement genetic classification and prioritize MYH11 variants for deeper mechanistic and in vivo study. Significance Statement Thoracic aortic aneurysms and dissections can arise when the muscular wall of the aorta is weakened and cannot withstand the pressure of blood flow. Mutations in MYH11, which encodes smooth muscle myosin II, are linked to inherited aortic disease, but how these variants alter vascular smooth muscle cell function remains unclear. Here, we directly visualize two MYH11 variants in living cells and measure how they disrupt myosin organization, stability, and force generation to different degrees. The pathogenic K1256del variant causes severe defects and prevents myosin stabilization during contraction, whereas the A1839V variant of uncertain significance causes milder defects. These findings reveal how MYH11 variants impair vascular smooth muscle function and provide a cell-based approach for evaluating poorly understood genetic variants.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.